English | Deutsch

m law group advises QureInvest in financing round of Transimmune AG

28.06.2012

QureInvest is a company investing equity in biotech and life science business with a focus on seed and early stage companies.

Transimmune AG is a biotechnology company focusing on research, development, manufacturing, commercialization and marketing of therapeutic solutions based on immune cell modulation.

Counsel QureInvest:
m law group: Dr. Hubert Besner, Axel Heltzel, Dr. Florian Anselm, Dr. Igor Barabash, Kathrin Brügger

Author: Dr. Hubert Besner
Practice Area: Start-up & Venture Capital
Industry: Life Science & Biotech